Logo image of MBLY

MOBILEYE GLOBAL INC-A (MBLY) Stock Fundamental Analysis

NASDAQ:MBLY - Nasdaq - US60741F1049 - Common Stock - Currency: USD

14.61  +0.21 (+1.46%)

After market: 14.6 -0.01 (-0.07%)

Fundamental Rating

4

Overall MBLY gets a fundamental rating of 4 out of 10. We evaluated MBLY against 81 industry peers in the Automobile Components industry. MBLY has a great financial health rating, but its profitability evaluates not so good. MBLY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year MBLY was profitable.
In the past year MBLY had a positive cash flow from operations.
In the past 5 years MBLY always reported negative net income.
Each year in the past 5 years MBLY had a positive operating cash flow.
MBLY Yearly Net Income VS EBIT VS OCF VS FCFMBLY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

1.2 Ratios

MBLY has a worse Return On Assets (-23.80%) than 91.36% of its industry peers.
Looking at the Return On Equity, with a value of -24.68%, MBLY is doing worse than 86.42% of the companies in the same industry.
Industry RankSector Rank
ROA -23.8%
ROE -24.68%
ROIC N/A
ROA(3y)-8.42%
ROA(5y)-5.38%
ROE(3y)-8.77%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
MBLY Yearly ROA, ROE, ROICMBLY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20 -25

1.3 Margins

Looking at the Gross Margin, with a value of 48.25%, MBLY belongs to the top of the industry, outperforming 98.77% of the companies in the same industry.
MBLY's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for MBLY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5Y-1.42%
MBLY Yearly Profit, Operating, Gross MarginsMBLY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

8

2. Health

2.1 Basic Checks

MBLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MBLY has more shares outstanding
There is no outstanding debt for MBLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MBLY Yearly Shares OutstandingMBLY Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 200M 400M 600M 800M
MBLY Yearly Total Debt VS Total AssetsMBLY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

MBLY has an Altman-Z score of 15.72. This indicates that MBLY is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 15.72, MBLY belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
MBLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 15.72
ROIC/WACCN/A
WACC9.03%
MBLY Yearly LT Debt VS Equity VS FCFMBLY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

MBLY has a Current Ratio of 7.64. This indicates that MBLY is financially healthy and has no problem in meeting its short term obligations.
MBLY's Current ratio of 7.64 is amongst the best of the industry. MBLY outperforms 97.53% of its industry peers.
A Quick Ratio of 6.38 indicates that MBLY has no problem at all paying its short term obligations.
The Quick ratio of MBLY (6.38) is better than 97.53% of its industry peers.
Industry RankSector Rank
Current Ratio 7.64
Quick Ratio 6.38
MBLY Yearly Current Assets VS Current LiabilitesMBLY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

The earnings per share for MBLY have decreased strongly by -33.33% in the last year.
MBLY shows a decrease in Revenue. In the last year, the revenue decreased by -0.38%.
The Revenue has been growing by 13.48% on average over the past years. This is quite good.
EPS 1Y (TTM)-33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%214.29%
Revenue 1Y (TTM)-0.38%
Revenue growth 3Y6.07%
Revenue growth 5Y13.48%
Sales Q2Q%83.26%

3.2 Future

MBLY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 52.12% yearly.
MBLY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.85% yearly.
EPS Next Y22.45%
EPS Next 2Y35%
EPS Next 3Y40.4%
EPS Next 5Y52.12%
Revenue Next Year6.9%
Revenue Next 2Y12.99%
Revenue Next 3Y17.14%
Revenue Next 5Y23.85%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MBLY Yearly Revenue VS EstimatesMBLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
MBLY Yearly EPS VS EstimatesMBLY Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 36.52, MBLY can be considered very expensive at the moment.
Based on the Price/Earnings ratio, MBLY is valued a bit more expensive than 76.54% of the companies in the same industry.
MBLY is valuated rather expensively when we compare the Price/Earnings ratio to 28.22, which is the current average of the S&P500 Index.
MBLY is valuated quite expensively with a Price/Forward Earnings ratio of 32.07.
76.54% of the companies in the same industry are cheaper than MBLY, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.86. MBLY is valued rather expensively when compared to this.
Industry RankSector Rank
PE 36.53
Fwd PE 32.07
MBLY Price Earnings VS Forward Price EarningsMBLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

MBLY's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. MBLY is more expensive than 85.19% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MBLY is valued a bit more expensive than the industry average as 70.37% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 29.96
EV/EBITDA 102.49
MBLY Per share dataMBLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

MBLY's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
MBLY's earnings are expected to grow with 40.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.63
PEG (5Y)N/A
EPS Next 2Y35%
EPS Next 3Y40.4%

0

5. Dividend

5.1 Amount

MBLY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MOBILEYE GLOBAL INC-A

NASDAQ:MBLY (5/2/2025, 8:08:12 PM)

After market: 14.6 -0.01 (-0.07%)

14.61

+0.21 (+1.46%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)04-24 2025-04-24/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners109.34%
Inst Owner Change-2.5%
Ins Owners3.55%
Ins Owner Change0.83%
Market Cap11.86B
Analysts74.12
Price Target19.69 (34.77%)
Short Float %23.05%
Short Ratio5.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.88%
Min EPS beat(2)4.12%
Max EPS beat(2)15.64%
EPS beat(4)4
Avg EPS beat(4)9.55%
Min EPS beat(4)0.46%
Max EPS beat(4)17.98%
EPS beat(8)7
Avg EPS beat(8)11.53%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.27%
Min Revenue beat(2)-1.09%
Max Revenue beat(2)0.55%
Revenue beat(4)3
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)1.6%
Revenue beat(8)4
Avg Revenue beat(8)-0.2%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.3%
PT rev (3m)-7.44%
EPS NQ rev (1m)16.53%
EPS NQ rev (3m)-15.39%
EPS NY rev (1m)-2.69%
EPS NY rev (3m)-29.53%
Revenue NQ rev (1m)4.72%
Revenue NQ rev (3m)-3.84%
Revenue NY rev (1m)-0.77%
Revenue NY rev (3m)-9.43%
Valuation
Industry RankSector Rank
PE 36.53
Fwd PE 32.07
P/S 6.4
P/FCF 29.96
P/OCF 25.29
P/B 0.98
P/tB 5.05
EV/EBITDA 102.49
EPS(TTM)0.4
EY2.74%
EPS(NY)0.46
Fwd EY3.12%
FCF(TTM)0.49
FCFY3.34%
OCF(TTM)0.58
OCFY3.95%
SpS2.28
BVpS14.84
TBVpS2.9
PEG (NY)1.63
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.8%
ROE -24.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.25%
FCFM 21.37%
ROA(3y)-8.42%
ROA(5y)-5.38%
ROE(3y)-8.77%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5Y-1.42%
F-Score6
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 14.31%
Cap/Sales 3.94%
Interest Coverage N/A
Cash Conversion 464.36%
Profit Quality N/A
Current Ratio 7.64
Quick Ratio 6.38
Altman-Z 15.72
F-Score6
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)18.23%
Cap/Depr(5y)20.31%
Cap/Sales(3y)5.18%
Cap/Sales(5y)7.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%214.29%
EPS Next Y22.45%
EPS Next 2Y35%
EPS Next 3Y40.4%
EPS Next 5Y52.12%
Revenue 1Y (TTM)-0.38%
Revenue growth 3Y6.07%
Revenue growth 5Y13.48%
Sales Q2Q%83.26%
Revenue Next Year6.9%
Revenue Next 2Y12.99%
Revenue Next 3Y17.14%
Revenue Next 5Y23.85%
EBIT growth 1Y-115.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year90.37%
EBIT Next 3Y68.79%
EBIT Next 5Y49.51%
FCF growth 1Y7.77%
FCF growth 3Y-11.23%
FCF growth 5Y4.5%
OCF growth 1Y1.52%
OCF growth 3Y-12.59%
OCF growth 5Y5.92%